Icahn School of Medicine at Mount Sinai - Investigational Drug Service — New York, New York

Icahn School of Medicine at Mount Sinai - Investigational Drug Service is a clinical research site located in New York, New York, United States 10029.

Crixeo Health Trust Score: 54/100 (POOR). This profile has not yet been claimed by the site owner.

Icahn School of Medicine at Mount Sinai - Investigational Drug Service has participated in 1 clinical trials.

Therapeutic areas: SARS-CoV-2 Infection, COVID-19.

Sponsors: BioNTech SE.

Sponsor Feasibility Report

Trust Score: 54/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Icahn School of Medicine at Mount Sinai - Investigational Drug Service?

Icahn School of Medicine at Mount Sinai - Investigational Drug Service has a Crixeo Trust Score of 54/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Icahn School of Medicine at Mount Sinai - Investigational Drug Service conducted?

Icahn School of Medicine at Mount Sinai - Investigational Drug Service has 1 clinical trials on record. Their work covers SARS-CoV-2 Infection, COVID-19.

Is Icahn School of Medicine at Mount Sinai - Investigational Drug Service accredited by Crixeo Health?

Icahn School of Medicine at Mount Sinai - Investigational Drug Service has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Icahn School of Medicine at Mount Sinai - Investigational Drug Service?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.